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Current practices to treat leishmaniasis suffer from poor efficacy and are associated with high toxicity. This induces side effects that 
make people discontinue treatments, leading to disease relapses and the emergence of resistant strains. Besides this, the high costs 
associated to most of the available therapeutic options are far from suitable for developing countries. 
Searching for alternatives to current treatments, we have used a high content-based platform previously implemented in the lab to 
screen about 40 different compounds against intracellular amastigotes (in bone marrow-derived macrophages, BMDM). From this 
screening, a set of quinolin-4(1H)-imines, which were previously shown to display antiplasmodial activity [1], emerged as the most 
interesting family of compounds. The three most active (5P2, 7P2 and 22P2) presented half maximal inhibitory concentrations (IC50) of 
0.9±0.1µM, 1.25±0.4µM and 0.7±0.2µM respectively, and selectivity indexes of 15-20 (host cell cytotoxicity evaluated also in BMDM). 
Interestingly, the efficiency exhibited by these compounds over intracellular amastigotes was more than tenfold superior to that observed 
against axenic amastigotes. We are investigating whether this occurs due to an inherent capacity of these compounds to directly acti-
vate macrophages, because the compounds are metabolized within these cells to a derivative more potent against Leishmania or, even, 
due to a metabolic alteration of intramacrophagic parasites, which become more prone to inhibition.
Quinolin-4(1H)-imines were initially designed to target mitochondrial cytochrome bc1 [1]. The observation that several of these com-
pounds have an inhibitory effect on the basal oxygen consumption of intact Leishmania amastigotes suggests that their mode of 
action could also include inhibition of cytochrome bc1 and/or other respiratory chain enzymes. In short, this study suggests that quino-
lin-4(1H)-imines might be an interesting chemotype in the search of new anti-Leishmania leads. 
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